LATEST

Off the Wire

IN FOCUS

Study Examines Hyperbaric Oxygen Therapy for Breast Cancer Patients

Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves breathing pure oxygen in a pressurized room or chamber. In these hyperbaric (high pressure) conditions, your lungs...

Nanotechnology-Enhanced Resveratrol Shows Promise in Treatment of Triple-Negative Breast Cancer

Yes, it's that kind of resveratrol--that found in red wine. But with a technical twist to ensure it's delivered properly. Triple-negative breast cancer (TNBC) is a type of...

Omega-3 Fatty Acid and Breast Cancer Prevention for Patients Hoping for Pregnancy

A pilot trial at the National Cancer Institute, conducted by the University of Kansas Cancer Center and led by Principal Investigator Lauren Nye aims to explore the...

LEARN MORE

RESEARCH

RESEARCH

LEARN MORE

AMA Introduces New CPT Code for Seno Medical’s Breast Imaging Technology

The American Medical Association (AMA) has recently introduced a new Current Procedural Terminology (CPT) code, specifically for the Imagio Breast Imaging System developed by...

Beyond Mammograms: How Cutting-Edge Technology is Revolutionizing Early Diagnosis

Groundbreaking research that could change the current imaging and mammogram paradigm has just been published in the imminent scientific publication, Nature. The work...

Talimogene Laherparepvec in HER2-Negative Breast Cancer: A Phase Ib Study

A new clinical study at the National Cancer Institute in the U.S. is looking into a treatment method for patients with a specific type...

New Strategies and Tech in Lymphedema Prevention Following Breast Cancer

Developing effective strategies for preventing breast cancer-related arm lymphedema (BCRAL) remains a significant unmet need in healthcare, as there are currently no effective treatments...

Advancements in HER2-Positive Breast Cancer: New Treatments Promise Improved Survival

Today we wanted to point to an outstanding interview with Dr. Nicholas P. McAndrew, an expert in breast cancer treatment. He recently shared insights on...

DRUG DEVELOPMENT